PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.27%
Revenue growth of 14.27% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
9.27%
Gross profit growth of 9.27% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
16.77%
Positive EBIT growth while Healthcare median is negative. Peter Lynch might see a strong competitive advantage in operations.
29.33%
Positive operating income growth while Healthcare is negative. Peter Lynch would spot a big relative advantage here.
31.60%
Net income growth of 31.60% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
31.60%
EPS growth of 31.60% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
31.60%
Diluted EPS growth of 31.60% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.86%
10Y CAGR of 77.86% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
81.50%
5Y CAGR of 81.50% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
44.91%
3Y CAGR of 44.91% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
149.69%
Net income/share CAGR of 149.69% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
103.51%
Net income/share CAGR of 103.51% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
27.68%
3Y net income/share CAGR of 27.68% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
198.41%
Equity/share CAGR of 198.41% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
123.92%
5Y equity/share CAGR > 1.5x Healthcare median of 8.74%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
56.55%
3Y equity/share CAGR > 1.5x Healthcare median of 4.85%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
160.87%
Dividend/share CAGR of 160.87% while Healthcare is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
84.62%
5Y dividend/share CAGR of 84.62% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
33.33%
3Y dividend/share CAGR of 33.33% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
-48.82%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
7.60%
Inventory growth of 7.60% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
13.64%
Asset growth of 13.64% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
5.21%
BV/share growth of 5.21% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
63.09%
Debt growth of 63.09% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-44.38%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.